Elena A. Goncharova

4.7k total citations
79 papers, 3.4k citations indexed

About

Elena A. Goncharova is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Elena A. Goncharova has authored 79 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pulmonary and Respiratory Medicine, 41 papers in Molecular Biology and 27 papers in Physiology. Recurrent topics in Elena A. Goncharova's work include Pulmonary Hypertension Research and Treatments (38 papers), PI3K/AKT/mTOR signaling in cancer (16 papers) and Tuberous Sclerosis Complex Research (14 papers). Elena A. Goncharova is often cited by papers focused on Pulmonary Hypertension Research and Treatments (38 papers), PI3K/AKT/mTOR signaling in cancer (16 papers) and Tuberous Sclerosis Complex Research (14 papers). Elena A. Goncharova collaborates with scholars based in United States, Russia and United Kingdom. Elena A. Goncharova's co-authors include Vera P. Krymskaya, Dmitry A. Goncharov, Reynold A. Panettieri, Andrew Eszterhas, Daniel J. Noonan, Ana L. Mora, Carla Irani, Poay N. Lim, Tatiana V. Kudryashova and John Sembrat and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Elena A. Goncharova

77 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elena A. Goncharova United States 35 1.4k 1.4k 1.1k 427 408 79 3.4k
Dmitry A. Goncharov United States 23 896 0.6× 691 0.5× 786 0.7× 257 0.6× 276 0.7× 45 2.0k
Vera P. Krymskaya United States 35 1.8k 1.3× 906 0.7× 1.8k 1.6× 755 1.8× 101 0.2× 86 3.8k
Cheng‐Han Lee Canada 36 1.1k 0.8× 1.3k 1.0× 284 0.3× 457 1.1× 324 0.8× 81 3.2k
Laura Rosanò Italy 35 2.1k 1.5× 483 0.4× 1.2k 1.0× 915 2.1× 335 0.8× 63 3.7k
Valeriana Di Castro Italy 33 2.0k 1.4× 433 0.3× 1.2k 1.1× 833 2.0× 323 0.8× 56 3.5k
Amilcar Flores‐Morales Sweden 36 1.7k 1.2× 521 0.4× 376 0.3× 1.0k 2.4× 235 0.6× 74 3.6k
Takaaki Sasaki Japan 27 898 0.6× 1.0k 0.8× 471 0.4× 725 1.7× 193 0.5× 115 3.4k
Kazuhito Ichikawa Japan 27 1.7k 1.2× 368 0.3× 371 0.3× 643 1.5× 568 1.4× 96 3.2k
Han Si United States 21 1.4k 1.0× 424 0.3× 513 0.5× 449 1.1× 401 1.0× 55 2.7k
Anna Bagnato Italy 46 3.3k 2.3× 897 0.7× 2.0k 1.7× 1.4k 3.4× 570 1.4× 124 6.2k

Countries citing papers authored by Elena A. Goncharova

Since Specialization
Citations

This map shows the geographic impact of Elena A. Goncharova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena A. Goncharova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena A. Goncharova more than expected).

Fields of papers citing papers by Elena A. Goncharova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena A. Goncharova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena A. Goncharova. The network helps show where Elena A. Goncharova may publish in the future.

Co-authorship network of co-authors of Elena A. Goncharova

This figure shows the co-authorship network connecting the top 25 collaborators of Elena A. Goncharova. A scholar is included among the top collaborators of Elena A. Goncharova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena A. Goncharova. Elena A. Goncharova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jheng, Jia-Rong, Yang Bai, Kentaro Noda, et al.. (2024). Skeletal Muscle SIRT3 Deficiency Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction. Circulation. 150(11). 867–883. 9 indexed citations
2.
Varghese, Mathews Valuparampil, Brenda Baggett, Dmitry A. Goncharov, et al.. (2024). Mitochondria as a primary determinant of angiogenic modality in pulmonary arterial hypertension. The Journal of Experimental Medicine. 221(11). 1 indexed citations
3.
Bogamuwa, Srimathi, Tanvir Hossain, Daniela Farkas, et al.. (2023). RAB7 deficiency impairs pulmonary artery endothelial function and promotes pulmonary hypertension. Journal of Clinical Investigation. 134(3). 17 indexed citations
4.
Goncharova, Elena A., Edna Nyangau, Mahalakshmi Shankaran, et al.. (2023). The D3‐creatine dilution method non‐invasively measures muscle mass in mice. Aging Cell. 22(8). e13897–e13897. 3 indexed citations
5.
Jiang, Lifeng, Dmitry A. Goncharov, Derek Lin, et al.. (2023). Abstract 14485: LDHA-Lactate Promotes Smooth Muscle Remodeling and Pulmonary Hypertension Through Lactylation of TOP1 and EMILIN1. Circulation. 148(Suppl_1).
6.
Ali, Mehboob, Mingjun Liu, Neil J. Kelly, et al.. (2023). A p53-TLR3 axis ameliorates pulmonary hypertension by inducing BMPR2 via IRF3. iScience. 26(2). 105935–105935. 11 indexed citations
7.
Shen, Yuanjun, Dmitry A. Goncharov, Andressa Peña, et al.. (2022). Cross-talk between TSC2 and the extracellular matrix controls pulmonary vascular proliferation and pulmonary hypertension. Science Signaling. 15(763). eabn2743–eabn2743. 14 indexed citations
8.
Daneva, Zdravka, Corina Marziano, Matteo Ottolini, et al.. (2021). Caveolar peroxynitrite formation impairs endothelial TRPV4 channels and elevates pulmonary arterial pressure in pulmonary hypertension. Proceedings of the National Academy of Sciences. 118(17). 60 indexed citations
9.
Sahoo, Sanghamitra, Yao Li, Daniel Simões de Jesus, et al.. (2021). Notch2 suppression mimicking changes in human pulmonary hypertension modulates Notch1 and promotes endothelial cell proliferation. American Journal of Physiology-Heart and Circulatory Physiology. 321(3). H542–H557. 21 indexed citations
10.
Neier, Kari, Noreene M. Shibata, Yuanjun Shen, et al.. (2021). Wilson Disease: Intersecting DNA Methylation and Histone Acetylation Regulation of Gene Expression in a Mouse Model of Hepatic Copper Accumulation. Cellular and Molecular Gastroenterology and Hepatology. 12(4). 1457–1477. 13 indexed citations
11.
Farkas, Daniela, Brennan Harmon, Carlyne D. Cool, et al.. (2020). Clonally selected primitive endothelial cells promote occlusive pulmonary arteriopathy and severe pulmonary hypertension in rats exposed to chronic hypoxia. Scientific Reports. 10(1). 1136–1136. 16 indexed citations
12.
Spiekerkoetter, Edda, Elena A. Goncharova, Christophe Guignabert, et al.. (2019). Hot topics in the mechanisms of pulmonary arterial hypertension disease: cancer‐like pathobiology, the role of the adventitia, systemic involvement, and right ventricular failure. Pulmonary Circulation. 9(4). 1–15. 24 indexed citations
13.
Farkas, Daniela, A. A. Roger Thompson, Hyun Ji, et al.. (2018). Toll-like Receptor 3 Is a Therapeutic Target for Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 199(2). 199–210. 50 indexed citations
14.
Kudryashova, Tatiana V., Dmitry A. Goncharov, Andressa Peña, et al.. (2016). HIPPO–Integrin-linked Kinase Cross-Talk Controls Self-Sustaining Proliferation and Survival in Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 194(7). 866–877. 100 indexed citations
15.
Pullamsetti, Soni Savai, Rajkumar Savai, Werner Seeger, & Elena A. Goncharova. (2016). T ranslational A dvances in the F ield of P ulmonary H ypertension . From Cancer Biology to New Pulmonary Arterial Hypertension Therapeutics. Targeting Cell Growth and Proliferation Signaling Hubs. American Journal of Respiratory and Critical Care Medicine. 195(4). 425–437. 108 indexed citations
16.
Sahoo, Sanghamitra, Daniel N. Meijles, Imad Al Ghouleh, et al.. (2016). MEF2C-MYOCD and Leiomodin1 Suppression by miRNA-214 Promotes Smooth Muscle Cell Phenotype Switching in Pulmonary Arterial Hypertension. PLoS ONE. 11(5). e0153780–e0153780. 47 indexed citations
17.
Goncharov, Dmitry A., Tatiana V. Kudryashova, Kaori Ihida‐Stansbury, et al.. (2013). Mammalian Target of Rapamycin Complex 2 (mTORC2) Coordinates Pulmonary Artery Smooth Muscle Cell Metabolism, Proliferation, and Survival in Pulmonary Arterial Hypertension. Circulation. 129(8). 864–874. 159 indexed citations
18.
Goncharova, Elena A., Dmitry A. Goncharov, Hengjiang Zhao, et al.. (2011). β2-Adrenergic Receptor Agonists Modulate Human Airway Smooth Muscle Cell Migration via Vasodilator-Stimulated Phosphoprotein. American Journal of Respiratory Cell and Molecular Biology. 46(1). 48–54. 34 indexed citations
19.
Goncharova, Elena A., Dmitry A. Goncharov, Daniel J. Noonan, & Vera P. Krymskaya. (2004). TSC2 modulates actin cytoskeleton and focal adhesion through TSC1-binding domain and the Rac1 GTPase. The Journal of Cell Biology. 167(6). 1171–1182. 89 indexed citations
20.
Goncharova, Elena A., Dmitry A. Goncharov, Andrew Eszterhas, et al.. (2002). Tuberin Regulates p70 S6 Kinase Activation and Ribosomal Protein S6 Phosphorylation. Journal of Biological Chemistry. 277(34). 30958–30967. 350 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026